Healthcare -
Biotechnology - NASDAQ - US
$ 42.365
-1.29 %
$ 3.92 B
Market Cap
-6.74
P/E
RARE - INTEREST INCOME & EXPENSE
Interest Income & Expense RARE - Ultragenyx Pharmaceutical Inc.
-63 M
LAST VALUE
-57.02%
2 YEAR CAGR
-124.12%
5 YEAR CAGR
0.00%
10 YEAR CAGR